How to Use CDISC’s ODM Standard for CRF Design Blog 如何使用 CDISC 的 ODM 标准设计 CRF Over the last decade, our industry has become familiar with Clinical Data Interchange Standards Consortium…Certara2024 年 9 月 25 日
How Clinical Trial Technology Streamlines the Research Process Blog 临床试验技术如何简化研究过程 Learn how innovative clinical trial technology helps to revolutionize research & ensure the swift rollout…Certara2024 年 9 月 25 日
Certara’s Simcyp Consortium Celebrates 25th Anniversary Press Release Certara Simcyp Consortium 庆祝成立 25 周年 The pre-competitive scientific research consortium of top pharmaceutical companies remains a critical force in advancing…Certara2024 年 9 月 24 日
Why cancer drug programs need human mass balance studies Blog 为什么癌症药物项目需要人体物质平衡研究 Historically, drug programs for oncology and other rapidly fatal diseases didn’t include mass balance studies…Certara2024 年 9 月 23 日
Certara Launches Early Development Solution to Reduce Failure Rates in Early-Stage Drug Development Announcement Certara 推出早期开发解决方案,降低早期药物开发的失败率 New solution offers early-stage developers a dedicated team of experts with combined experience in end-to-end…Certara2024 年 9 月 19 日
International Congress of Parkinson’s Disease and Movement Disorders® Conference 国际帕金森病和运动障碍大会® Certara2024 年 9 月 18 日
A close examination of BCRP’s role in lactation and methods for predicting drug distribution into milk Publication A close examination of BCRP’s role in lactation and methods for predicting drug distribution into milk The article, authored by Caroline Sychterz, Hong Shen, Yueping Zhang, Michael Sinz, Amin Rostami-Hodjegan, Brian…Certara2024 年 9 月 18 日
Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer Drug Press Release Certara 与 Ichnos Glenmark Innovation 合作优化了潜在首创癌症药物的剂量策略 Preclinical research on the trispecific antibody, ISB 2001, published in Nature Cancer leveraged virtual trials to…Certara2024 年 9 月 18 日